Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
6.12
-0.19 (-3.01%)
At close: Oct 16, 2026, 4:00 PM EDT
6.08
-0.04 (-0.58%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $792.14 million as of October 16, 2026. It is the 11,549th most valuable company in the world and the 2,378th biggest in the United States. Its market cap has increased by 56.95% in one year.
Market Cap
792.14M
Enterprise Value
326.28M
1-Year Change
56.95%
Global Rank
Country Rank
#2,378 United States
Category
ChartMarket Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has decreased from $901.92M to $792.14M, a decrease of -12.17%. That is a compound annual growth rate of -5.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 792.14M | -22.25% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 839.48M |
| Arbutus Biopharma | 828.98M |
| ArriVent BioPharma | 798.79M |
| Odyssey Therapeutics | 795.45M |
| Ardelyx | 794.91M |
| SpyGlass Pharma | 792.38M |
| Corvus Pharmaceuticals | 789.05M |
| Ginkgo Bioworks Holdings | 776.43M |